Pharmaceutical Services
In today's ever-changing research climate, the objective is to get the right therapy to the right patient. Caris Life Sciences™ is working with leading biopharmaceutical companies to fulfill this challenge.
Highly-targeted therapeutics will individualize medicine and take the guess work out of treatment selections for cancer and complex diseases. Caris develops and performs advanced-molecular testing necessary for modern clinical trials with investigational drugs and biologics. Caris also has the capability to commercialize the companion diagnostics that result from these trials.
Caris' bio-sample management tools offer complete specimen collection and clinical trial-support services. Caris can handle every step of specimen management, from collection to storage. Company clients have access to Caris' web-based tracking and reporting program, which provides live updates on every specimen’s progress through the system.
Caris pairs a broad technology base with experience in custom-assay development to provide a wide variety of molecular profiling services. The company's capabilities include:
- Customized Immunohistochemistry
- FISH (including custom probes capabilities)
- Microarray Analysis
- Sequence Analysis
- SNP Analysis
- PCR / qPCR / RT-qPCR
- aCGH Analysis
- Circulating Tumor Cell Analysis
When it comes to managing the creation of companion diagnostics, the Caris team provides expertise in the identification, validation, and registration of novel biomarkers and powerful new diagnostic profiling tests. At the commercialization stage, Caris can manage CLIA validation and interactions with regulatory authorities worldwide.
